Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer as a bridge to transplantation or surgery
Record ID 32015000334
English
Authors' objectives:
Radioactive yttrium-90 (90Y) microspheres offer a selective internal radiation therapy (SIRT) (also referred to as transarterial or transcatheter radioembolization [TARE], radioembolization, or brachytherapy) for primary tumors of the liver. A trained specialist injects radioactive microspheres into hepatic arteries that supply blood to tumor(s). The goal of the procedure is to irradiate and destroy the tumor(s) while sparing normal liver tissue.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=17182
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Carcinoma, Hepatocellular
- Embolization, Therapeutic
- Liver Transplantation
- Liver Neoplasms
- Neoadjuvant Therapy
- Neoplasm Staging
- Yttrium Radioisotopes
- Microspheres
- Treatment Outcome
- Hepatic Artery
- Surgical Procedures, Operative
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2014 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.